| Ytd | -69.47% | |
| 1y | -96.00% |
| Open | 0.51 | Prev Close | 0.52 | Low | 0.50 | High | 0.55 | Mkt Cap | 5.84M |
| Vol | 113.32K | Avg Vol | 649.84K | EPS | -5.06 | P/E | N/A | Forward P/E | -0.43 |
| Beta | -1.29 | Short Ratio | 0.02 | Inst. Own | 10.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.75 | 200-d Avg | 3.63 | 1yr Est | 7.50 |
GNPX News
Patent Covers Acclaim-3 Clinical Trials Combining REQORSA Gene Therapy with Genentech, Inc.'s Te
https://www.sec.gov/Archives/edgar/data/1595248/000143774926019760/gnpx20260518_s3.htm
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene the
Genprex (NASDAQ:GNPX) reported quarterly losses of $(0.64) per share. This is a 95.08 percent increa
The health care sector has oversold stocks with RSI below 30, presenting an opportunity for traders
Strengthens Patent Estate and Expands Protection in Another Target MarketAUSTIN, Texas, April 30, 20
TROP2 and PTEN Biomarkers May Predict Patient Response to Reqorsa® Gene TherapyREQORSA Induced Apopt
A Congress member continues to buy small cap stocks. Here's the latest names added to his invest
A member of Congress is buying stock in two small cap companies in 2026. Here's the stocks and w
The list of the top 10 members of Congress for 2025 investment portfolio gains. Where did Marjorie T
A congressman bought shares of a small cap company recently. Here's a look at the stock and why
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biote